Researchers have used pluripotent stem cells to make thymus organoids that support the development of patient-specific T-cells. The proof-of-concept work provides the basis for studying human thymus ...

The seemingly unassuming organ has become an emerging target for healthspan, longevity, and precision oncology.

(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...

Researchers at the Francis Crick Institute have identified stem cells in the human thymus for the first time. These cells represent a potential new target to understand immune diseases and cancer and ...

Biomedical scientists have confirmed that newly discovered cells in the thymus are just like M cells, which are mostly known for their presence in the intestinal epithelium. It came as a surprise to ...

Scientists hoping to discover better ways to boost immune function — which could lengthen our healthspan and protect immunocompromised patients — may have a new target, according to findings published ...

People with a healthy thymus gland live longer and are less likely to fall ill. In addition, immunotherapies are more often successful in patients with a healthy thymus. This is shown by two ...

As populations age worldwide, the decline of the immune system, a process known as immunosenescence, has become a critical biomedical challenge. This decline leads to increased susceptibility to ...

The thymus is one of the most important organs of the immune system, where T cells learn to distinguish the body’s own tissue from foreign tissue – a decisive step in preventing autoimmune diseases.

T cells are incredible. They detect foreign or abnormal proteins with remarkable specificity. Some directly kill cells containing these proteins while others call to additional components of the ...